Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation

Progress in Molecular Biology and Translational Science

Volumn 99, Issue C, 2011, Pages 51-103

  Zögg, Thomas ^a   Brandstetter, Hans ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Activation complex; Activity regulation; Hemophilia; Multistep regulation; Zymogenenzyme transition

Indexed keywords

EID: 78751607573     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385504-6.00002-6     Document Type: Chapter

References (220)

1. T. Zgg, and H. Brandstetter Activation mechanisms of coagulation factor IX Biol Chem 390 2009 391 400
2. R. Byrne, R.P. Link, and F.J. Castellino A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates J Biol Chem 255 1980 5336 5341
3. B.J. McRae, K. Kurachi, R.L. Heimark, K. Fujikawa, E.W. Davie, and J.C. Powers Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates Biochemistry 20 1981 7196 7206
4. B.W. Matthews, P.B. Sigler, R. Henderson, and D.M. Blow Three-dimensional structure of tosyl-alpha-chymotrypsin Nature 214 1967 652 656
5. W. Bode, and R. Huber Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin FEBS Lett 68 1976 231 236
6. W. Bode, P. Schwager, and R. Huber The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 resolution J Mol Biol 118 1978 99 112
7. H. Fehlhammer, W. Bode, and R. Huber Crystal structure of bovine trypsinogen at 1-8 resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin J Mol Biol 111 1977 415 438
8. D. Wang, W. Bode, and R. Huber Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 resolution J Mol Biol 185 1985 595 624
9. W.L. DeLano The case for open-source software in drug discovery Drug Discov Today 10 2005 213 217
10. M.J. Sippl, and M. Wiederstein A note on difficult structure alignment problems Bioinformatics 24 2008 426 427
11. S.P. Bajaj, S.I. Rapaport, and W.A. Russell Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX Biochemistry 22 1983 4047 4053
12. D. Gailani Activation of factor IX by factor XIa Trends Cardiovasc Med 10 2000 198 204
13. J.H. Lawson, and K.G. Mann Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation J Biol Chem 266 1991 11317 11327
14. E. Papagrigoriou, P.A. McEwan, P.N. Walsh, and J. Emsley Crystal structure of the factor XI zymogen reveals a pathway for transactivation Nat Struct Mol Biol 13 2006 557 558
15. K. Fujikawa, M.E. Legaz, H. Kato, and E.W. Davie The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent) Biochemistry 13 1974 4508 4516
16. F.A. Baglia, B.A. Jameson, and P.N. Walsh Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa J Biol Chem 266 1991 24190 24197
17. D. Gailani, D. Ho, M.F. Sun, Q. Cheng, and P.N. Walsh Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential Blood 97 2001 3117 3122
18. A.S. Wolberg, D.P. Morris, and D.W. Stafford Factor IX activation by factor XIa proceeds without release of a free intermediate Biochemistry 36 1997 4074 4079
19. D. Samuel, H. Cheng, P.W. Riley, A.A. Canutescu, C. Nagaswami, and J.W. Weisel Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation Proc Natl Acad Sci USA 104 2007 15693 15698
20. T. Zgg, and H. Brandstetter Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa Structure 17 2009 1669 1678
21. A. Takaki, D.L. Enfield, and A.R. Thompson Cleavage and inactivation of factor IX by granulocyte elastase J Clin Invest 72 1983 1706 1715
22. D.L. Enfield, and A.R. Thompson Cleavage and activation of human factor IX by serine proteases Blood 64 1984 821 831
23. H. Takeya, S. Nishida, T. Miyata, S. Kawada, Y. Saisaka, and T. Morita Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains J Biol Chem 267 1992 14109 14117
24. P.A. Lindquist, K. Fujikawa, and E.W. Davie Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom J Biol Chem 253 1978 1902 1909
25. T. Imamura, S. Tanase, T. Hamamoto, J. Potempa, and J. Travis Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis Biochem J 353 2001 325 331
26. R. Wallin, C. Stanton, and R.P. Ross Intracellular proteolytic processing of the two-chain vitamin K-dependent coagulation factor X Thromb Res 73 1994 395 403
27. M. Himmelspach, M. Pfleiderer, B.E. Fischer, B. Plaimauer, G. Antoine, and F.G. Falkner Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro Thromb Res 97 2000 51 67
28. K. Iijima, M. Murakami, O. Kimura, F. Murakami, T. Shimomura, and S. Ikawa A dysfunctional factor X (factor X Kurayoshi) with a substitution of Arg 139 for Ser at the carboxyl-terminus of the light chain Thromb Res 101 2001 311 316
29. K. Sichler, E. Kopetzki, R. Huber, W. Bode, K.P. Hopfner, and H. Brandstetter Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop J Biol Chem 278 2003 4121 4126
30. E.J. Duffy, and P. Lollar Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191 J Biol Chem 267 1992 7821 7827
31. P.J. Lenting, H. ter Maat, P.P. Clijsters, M.J. Donath, J.A. van Mourik, and K. Mertens Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme J Biol Chem 270 1995 14884 14890
32. M. Berrettini, R.R. Schleef, M.J. Heeb, P. Hopmeier, and J.H. Griffin Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells J Biol Chem 267 1992 19833 19839
33. Y. Nemerson, and B. Furie Zymogens and cofactors of blood coagulation CRC Crit Rev Biochem 9 1980 45 85
34. G. van Dieijen, J.L. van Rijn, J.W. Govers-Riemslag, H.C. Hemker, and J. Rosing Assembly of the intrinsic factor X activating complexInteractions between factor IXa, factor VIIIa and phospholipid Thromb Haemost 53 1985 396 400
35. E. Gyzander, E. Eriksson, and A.C. Teger-Nilsson A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharose Thromb Res 35 1984 547 558
36. R.A. Allen An enhancing effect of poly-lysine on the activation of plasminogen Thromb Haemost 47 1982 41 45
37. V. Vagenende, M.G. Yap, and B.L. Trout Mechanisms of protein stabilization and prevention of protein aggregation by glycerol Biochemistry 48 2009 11084 11096
38. J. Strzebecher, E. Kopetzki, W. Bode, and K.P. Hopfner Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols FEBS Lett 412 1997 295 300
39. J.A. Kolkman, P.J. Lenting, and K. Mertens Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity Biochem J 339 Pt 2 1999 217 221
40. J.P. Sheehan, and T.M. Phan Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism Biochemistry 40 2001 4980 4989
41. H. Brandstetter, M. Bauer, R. Huber, P. Lollar, and W. Bode X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B Proc Natl Acad Sci USA 92 1995 9796 9800
42. K.P. Hopfner, A. Lang, A. Karcher, K. Sichler, E. Kopetzki, and H. Brandstetter Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding Structure 7 1999 989 996
43. A. Rubboli Efficacy and safety of low-molecular-weight heparins as an adjunct to thrombolysis in acute ST-elevation myocardial infarction Curr Cardiol Rev 4 2008 63 71
44. G. Camporese, and E. Bernardi Low-molecular-weight heparin for thromboprophylaxis Curr Opin Pulm Med 15 2009 443 454
45. M.S. Bosner, T. Gulick, D.J. Riley, C.A. Spilburg, and L.G. Lange Heparin-modulated binding of pancreatic lipase and uptake of hydrolyzed triglycerides in the intestine J Biol Chem 264 1989 20261 20264
46. C.A. Spilburg, D.G. Cox, X. Wang, B.A. Bernat, M.S. Bosner, and L.G. Lange Identification of a species specific regulatory site in human pancreatic cholesterol esterase Biochemistry 34 1995 15532 15538
47. P.F. Neuenschwander Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa Biochemistry 43 2004 2978 2986
48. T.M. Misenheimer, Y. Buyue, and J.P. Sheehan The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X Biochemistry 46 2007 7886 7895
49. L. Yang, C. Manithody, and A.R. Rezaie Localization of the heparin binding exosite of factor IXa J Biol Chem 277 2002 50756 50760
50. Q.P. Yuan, E.N. Walke, and J.P. Sheehan The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin Biochemistry 44 2005 3615 3625
51. D.J. Johnson, J. Langdown, and J.A. Huntington Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex Proc Natl Acad Sci USA 107 2010 645 650
52. Y. Hitomi, C.E. Outten, and T.V. O'Halloran Extreme zinc-binding thermodynamics of the metal sensor/regulator protein, ZntR J Am Chem Soc 123 2001 8614 8615
53. M. Morena, J.Y. Bosc, I. Jaussent, A.M. Dupuy, N. Terrier, and H. Leray-Moragues The role of mineral metabolism and inflammation on dialysis vascular access failure J Vasc Access 7 2006 77 82
54. M.R. McDonald, and M. Kunitz The effect of calcium and other ions on the autocatalytic formation of trypsin from trypsinogen J Gen Physiol 25 1941 53 73
55. H. Brandstetter, A. Kuhne, W. Bode, R. Huber, W. von der Saal, and K. Wirthensohn X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition J Biol Chem 271 1996 29988 29992
56. Q.D. Dang, and E. Di Cera Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases Proc Natl Acad Sci USA 93 1996 10653 10656
57. E. Di Cera, E.R. Guinto, A. Vindigni, Q.D. Dang, Y.M. Ayala, and M. Wuyi The Na+ binding site of thrombin J Biol Chem 270 1995 22089 22092
58. C.M. Wells, and E. Di Cera Thrombin is a Na(+)-activated enzyme Biochemistry 31 1992 11721 11730
59. D. Monnaie, D. Arosio, N. Griffon, T. Rose, A.R. Rezaie, and E. Di Cera Identification of a binding site for quaternary amines in factor Xa Biochemistry 39 2000 5349 5354
60. 2+ sites in factor VIIa J Biol Chem 281 2006 24873 24888
61. M.M. Harding Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium Acta Crystallogr D Biol Crystallogr 58 2002 872 874
62. K. Sichler, D.W. Banner, A. D'Arcy, K.P. Hopfner, R. Huber, and W. Bode Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions J Mol Biol 322 2002 591 603
63. K. Scharer, M. Morgenthaler, R. Paulini, U. Obst-Sander, D.W. Banner, and D. Schlatter Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of factor Xa bound to a quaternary ammonium ion ligand Angew Chem Int Ed Engl 44 2005 4400 4404
64. P.S. Gandhi, Z. Chen, F.S. Mathews, and E. Di Cera Structural identification of the pathway of long-range communication in an allosteric enzyme Proc Natl Acad Sci USA 105 2008 1832 1837
65. S. Butenas, T. Orfeo, and K.G. Mann Tissue factor activity and function in blood coagulation Thromb Res 122 Suppl. 1 2008 S42 46
66. P.E. Bock, P. Panizzi, and I.M. Verhamme Exosites in the substrate specificity of blood coagulation reactions J Thromb Haemost 5 Suppl 1 2007 81 94
67. H.M. Spronk, J.W. Govers-Riemslag, and H. ten Cate The blood coagulation system as a molecular machine Bioessays 25 2003 1220 1228
68. C.J. Davidson, E.G. Tuddenham, and J.H. McVey 450 million years of hemostasis J Thromb Haemost 1 2003 1487 1494
69. K. Harlos, D.M. Martin, D.P. O'Brien, E.Y. Jones, D.I. Stuart, and I. Polikarpov Crystal structure of the extracellular region of human tissue factor Nature 370 1994 662 666
70. D.W. Banner, A. D'Arcy, C. Chene, F.K. Winkler, A. Guha, and W.H. Konigsberg The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor Nature 380 1996 41 46
71. C. Eigenbrot, D. Kirchhofer, M.S. Dennis, L. Santell, R.A. Lazarus, and J. Stamos The factor VII zymogen structure reveals reregistration of beta strands during activation Structure 9 2001 627 636
72. P.F. Neuenschwander, D.E. Branam, and J.H. Morrissey Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity Thromb Haemost 70 1993 970 977
73. S.K. Mandal, U.R. Pendurthi, and L.V. Rao Cellular localization and trafficking of tissue factor Blood 107 2006 4746 4753
74. S. Higashi, N. Matsumoto, and S. Iwanaga Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity J Biol Chem 271 1996 26569 26574
75. W. Bode, I. Mayr, U. Baumann, R. Huber, S.R. Stone, and J. Hofsteenge The refined 1.9 crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment EMBO J 8 1989 3467 3475
76. A.C. Pike, A.M. Brzozowski, S.M. Roberts, O.H. Olsen, and E. Persson Structure of human factor VIIa and its implications for the triggering of blood coagulation Proc Natl Acad Sci USA 96 1999 8925 8930
77. D. Zhong, M.S. Bajaj, A.E. Schmidt, and S.P. Bajaj The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor J Biol Chem 277 2002 3622 3631
78. P.F. Neuenschwander, and J.H. Morrissey Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X J Biol Chem 269 1994 8007 8013
79. K.G. Mann, T. Orfeo, S. Butenas, A. Undas, and K. Brummel-Ziedins Blood coagulation dynamics in haemostasis Hamostaseologie 29 2009 7 16
80. P. Lollar, G.J. Knutson, and D.N. Fass Activation of porcine factor VIII:C by thrombin and factor Xa Biochemistry 24 1985 8056 8064
81. P. Lollar, and C.G. Parker Subunit structure of thrombin-activated porcine factor VIII Biochemistry 28 1989 666 674
82. F.S. London, M. Marcinkiewicz, and P.N. Walsh PAR-1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium Biochemistry 45 2006 7289 7298
83. H. Andersen, D.L. Greenberg, K. Fujikawa, W. Xu, D.W. Chung, and E.W. Davie Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity Proc Natl Acad Sci USA 96 1999 11189 11193
84. B.W. Shen, P.C. Spiegel, C.H. Chang, J.W. Huh, J.S. Lee, and J. Kim The tertiary structure and domain organization of coagulation factor VIII Blood 111 2008 1240 1247
85. T.E. Adams, M.F. Hockin, K.G. Mann, and S.J. Everse The crystal structure of activated protein C-inactivated bovine factor Va: implications for cofactor function Proc Natl Acad Sci USA 101 2004 8918 8923
86. J.C. Ngo, M. Huang, D.A. Roth, B.C. Furie, and B. Furie Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex Structure 16 2008 597 606
87. K.P. Pratt, B.W. Shen, K. Takeshima, E.W. Davie, K. Fujikawa, and B.L. Stoddard Structure of the C2 domain of human factor VIII at 1.5 resolution Nature 402 1999 439 442
88. Z. Liu, L. Lin, C. Yuan, G.A. Nicolaes, L. Chen, and E.J. Meehan Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding J Biol Chem 285 2010 8824 8829
89. J.L. Newell, and P.J. Fay Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII J Biol Chem 282 2007 25367 25375
90. P.J. Fay, M. Mastri, M.E. Koszelak, and H. Wakabayashi Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA J Biol Chem 276 2001 12434 12439
91. P.J. Fay, and P.V. Jenkins Mutating factor VIII: lessons from structure to function Blood Rev 19 2005 15 27
92. K.A. Lapan, and P.J. Fay Localization of a factor X interactive site in the A1 subunit of factor VIIIa J Biol Chem 272 1997 2082 2088
93. P.J. Fay, and K. Koshibu The A2 subunit of factor VIIIa modulates the active site of factor IXa J Biol Chem 273 1998 19049 19054
94. L.M. O'Brien, L.V. Medved, and P.J. Fay Localization of factor IXa and factor VIIIa interactive sites J Biol Chem 270 1995 27087 27092
95. P.J. Lenting, J.W. van de Loo, M.J. Donath, J.A. van Mourik, and K. Mertens The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX J Biol Chem 271 1996 1935 1940
96. K. Patsialas, C. Koutsas, P. Makris, and M. Liakopoulou-Kyriakides Peptide analogues of 1811-1818 loop of the A3 subunit of the light chain A3-C1-C2 of FVIII of blood coagulation: biological evaluation Amino Acids 39 2010 481 488
97. H. Meems, A.B. Meijer, D.B. Cullinan, K. Mertens, and G.E. Gilbert Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity Blood 114 2009 3938 3946
98. T.C. Hsu, K.P. Pratt, and A.R. Thompson The factor VIII C1 domain contributes to platelet binding Blood 111 2008 200 208
99. M. Jacquemin, A. Benhida, K. Peerlinck, B. Desqueper, L. Vander Elst, and R. Lavend'homme A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor Blood 95 2000 156 163
100. G.E. Gilbert, R.J. Kaufman, A.A. Arena, H. Miao, and S.W. Pipe Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs J Biol Chem 277 2002 6374 6381
101. P.H. Celie, G. Van Stempvoort, C. Fribourg, L.J. Schurgers, P.J. Lenting, and K. Mertens The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domain J Biol Chem 277 2002 20214 20220
102. S.P. Bajaj Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants Thromb Haemost 82 1999 218 225
103. K.P. Hopfner, H. Brandstetter, A. Karcher, E. Kopetzki, R. Huber, and R.A. Engh Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants EMBO J 16 1997 6626 6635
104. J.A. Kolkman, and K. Mertens Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII Biochemistry 39 2000 7398 7405
105. T. Soeda, K. Nogami, K. Nishiya, M. Takeyama, K. Ogiwara, and Y. Sakata The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor xase complex J Biol Chem 284 2009 3379 3388
106. H. Wakabayashi, A.E. Griffiths, and P.J. Fay Factor VIII lacking the C2 domain retains cofactor activity in vitro J Biol Chem 285 2010 25176 25184
107. L. Autin, M.A. Miteva, W.H. Lee, K. Mertens, K.P. Radtke, and B.O. Villoutreix Molecular models of the procoagulant factor VIIIa-factor IXa complex J Thromb Haemost 3 2005 2044 2056
108. L.M. O'Brien, M. Mastri, and P.J. Fay Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase Blood 95 2000 1714 1720
109. P.J. Fay, J.V. Coumans, and F.J. Walker von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation J Biol Chem 266 1991 2172 2177
110. J.L. Plantier, V. Rolli, C. Ducasse, Y. Dargaud, N. Enjolras, and H. Boukerche Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency J Thromb Haemost 8 2010 286 293
111. P.J. Fay, T.L. Beattie, L.M. Regan, L.M. O'Brien, and R.J. Kaufman Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis J Biol Chem 271 1996 6027 6032
112. A. Girolami, P. Scarparo, R. Scandellari, and E. Allemand Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: a critical evaluation Am J Hematol 83 2008 668 671
113. P. Fuentes-Prior, K. Fujikawa, and K.P. Pratt New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures Curr Protein Pept Sci 3 2002 313 339
114. M.F. Hockin, K.C. Jones, S.J. Everse, and K.G. Mann A model for the stoichiometric regulation of blood coagulation J Biol Chem 277 2002 18322 18333
115. K.G. Mann, M.F. Hockin, K.J. Begin, and M. Kalafatis Activated protein C cleavage of factor Va leads to dissociation of the A2 domain J Biol Chem 272 1997 20678 20683
116. S. Macedo-Ribeiro, W. Bode, R. Huber, M.A. Quinn-Allen, S.W. Kim, and T.L. Ortel Crystal structures of the membrane-binding C2 domain of human coagulation factor V Nature 402 1999 434 439
117. S. Yegneswaran, R.M. Mesters, and J.H. Griffin Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex J Biol Chem 278 2003 33312 33318
118. M. Steen, S. Tran, L. Autin, B.O. Villoutreix, A.L. Tholander, and B. Dahlback Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis J Biol Chem 283 2008 20805 20812
119. E. Thorelli, R.J. Kaufman, and B. Dahlback Cleavage requirements for activation of factor V by factor Xa Eur J Biochem 247 1997 12 20
120. L.V. Rao, and S.I. Rapaport The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro Blood 72 1988 396 401
121. K. Nogami, H. Wakabayashi, and P.J. Fay Mechanisms of factor Xa-catalyzed cleavage of the factor VIIIa A1 subunit resulting in cofactor inactivation J Biol Chem 278 2003 16502 16509
122. M.J. Heeb, and J.H. Griffin Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements Blood Cells Mol Dis 29 2002 190 199
123. R.C. Becker Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy J Thromb Thrombolysis 18 2004 153 155
124. S.J. Freedman, M.D. Blostein, J.D. Baleja, M. Jacobs, B.C. Furie, and B. Furie Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX J Biol Chem 271 1996 16227 16236
125. H.J. Brinkman, P. Koster, K. Mertens, and J.A. van Mourik Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation Biochem J 323 Pt 3 1997 735 740
126. U.R. Pendurthi, and L.V. Rao Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces Semin Hematol 45 2008 S21 24
127. C.T. Griffin, Y. Srinivasan, Y.W. Zheng, W. Huang, and S.R. Coughlin A role for thrombin receptor signaling in endothelial cells during embryonic development Science 293 2001 1666 1670
128. T.R. Baird, and P.N. Walsh The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation J Biol Chem 277 2002 38462 38467
129. T.R. Baird, and P.N. Walsh Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation J Biol Chem 277 2002 28498 28503
130. L.K. Jennings Role of platelets in atherothrombosis Am J Cardiol 103 2009 4A 10A
131. N. Busso, V. Chobaz-Peclat, J. Hamilton, P. Spee, N. Wagtmann, and A. So Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation Arthritis Res Ther 10 2008 R42
132. P.N. Walsh Platelet coagulation-protein interactions Semin Thromb Hemost 30 2004 461 471
133. K.E. Sletnes Role of phospholipids in hemostasis Tidsskr Nor Laegeforen 113 1993 2238 2241
134. X. Yang, and P.N. Walsh An ordered sequential mechanism for factor IX and Factor IXa binding to platelet receptors in the assembly of the factor X-activating complex Biochem J 390 2005 157 167
135. X. Yang, Y.J. Chang, S.W. Lin, and P.N. Walsh Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets J Biol Chem 279 2004 46400 46405
136. S.S. Ahmad, F.S. London, and P.N. Walsh The assembly of the factor X-activating complex on activated human platelets J Thromb Haemost 1 2003 48 59
137. M.Y. Wong, J.A. Gurr, and P.N. Walsh The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex Biochemistry 38 1999 8948 8960
138. A.J. Reininger Coagulation activity of platelets Hamostaseologie 27 2007 247 250
139. B. Nagy Jr., Z. Simon, Z. Bagoly, L. Muszbek, and J. Kappelmayer Binding of plasma factor XIII to thrombin-receptor activated human platelets Thromb Haemost 102 2009 83 89
140. C. Schulz, N.V. Leuschen, T. Frohlich, M. Lorenz, S. Pfeiler, and C.A. Gleissner Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation Blood 115 2010 4102 4110
141. I. Canobbio, C. Balduini, and M. Torti Signalling through the platelet glycoprotein Ib-V-IX complex Cell Signal 16 2004 1329 1344
142. D. Dormann, K.J. Clemetson, and B.E. Kehrel The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity Blood 96 2000 2469 2478
143. T.C. White-Adams, M.A. Berny, E.I. Tucker, J.M. Gertz, D. Gailani, and R.T. Urbanus Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2) Arterioscler Thromb Vasc Biol 29 2009 1602 1607
144. P.J. Larson, R.M. Camire, D. Wong, N.C. Fasano, D.M. Monroe, and P.B. Tracy Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles Biochemistry 37 1998 5029 5038
145. C. Schick, P.A. Pemberton, G.P. Shi, Y. Kamachi, S. Cataltepe, and A.J. Bartuski Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis Biochemistry 37 1998 5258 5266
146. J.C. Rau, L.M. Beaulieu, J.A. Huntington, and F.C. Church Serpins in thrombosis, hemostasis and fibrinolysis J Thromb Haemost 5 Suppl. 1 2007 102 115
147. K.M. O'Malley, S.A. Nair, H. Rubin, and B.S. Cooperman The kinetic mechanism of serpin-proteinase complex formation. An intermediate between the michaelis complex and the inhibited complex J Biol Chem 272 1997 5354 5359
148. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 926
149. R.A. Engh, R. Huber, W. Bode, and A.J. Schulze Divining the serpin inhibition mechanism: a suicide substrate 'springe'? Trends Biotechnol 13 1995 503 510
150. O. Egeberg Inherited antithrombin deficiency causing thrombophilia Thromb Diath Haemorrh 13 1965 516 530
151. V.S. Lindo, V.V. Kakkar, and E. Melissari Cleaved antithrombin (ATc): a new marker for thrombin generation and activation of the coagulation system Br J Haematol 89 1995 157 162
152. C. Manithody, L. Yang, and A.R. Rezaie Role of basic residues of the autolysis loop in the catalytic function of factor Xa Biochemistry 41 2002 6780 6788
153. L. Yang, C. Manithody, S.T. Olson, and A.R. Rezaie Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa J Biol Chem 278 2003 25032 25038
154. D.J. Johnson, W. Li, T.E. Adams, and J.A. Huntington Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation EMBO J 25 2006 2029 2037
155. S.T. Olson, and I. Bjork Regulation of thrombin activity by antithrombin and heparin Semin Thromb Hemost 20 1994 373 409
156. G. Izaguirre, W. Zhang, R. Swanson, T. Bedsted, and S.T. Olson Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin J Biol Chem 278 2003 51433 51440
157. S.J. Rogers, C.W. Pratt, H.C. Whinna, and F.C. Church Role of thrombin exosites in inhibition by heparin cofactor II J Biol Chem 267 1992 3613 3617
158. R. Skinner, J.P. Abrahams, J.C. Whisstock, A.M. Lesk, R.W. Carrell, and M.R. Wardell The 2.6 structure of antithrombin indicates a conformational change at the heparin binding site J Mol Biol 266 1997 601 609
159. Y.J. Chuang, R. Swanson, S.M. Raja, and S.T. Olson Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin J Biol Chem 276 2001 14961 14971
160. A. Dementiev, M. Petitou, J.M. Herbert, and P.G. Gettins The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity Nat Struct Mol Biol 11 2004 863 867
161. X. Han, R. Fiehler, and G.J. Broze Jr. Characterization of the protein Z-dependent protease inhibitor Blood 96 2000 3049 3055
162. X. Han, Z.F. Huang, R. Fiehler, and G.J. Broze Jr. The protein Z-dependent protease inhibitor is a serpin Biochemistry 38 1999 11073 11078
163. Z. Wei, Y. Yan, R.W. Carrell, and A. Zhou Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X Blood 114 2009 3662 3667
164. X. Huang, A. Dementiev, S.T. Olson, and P.G. Gettins Basis for the specificity and activation of the serpin ZPI as an inhibitor of membrane-associated factor Xa J Biol Chem 285 2010 20399 20409
165. X. Huang, R. Swanson, G.J. Broze Jr., and S.T. Olson Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa J Biol Chem 283 2008 29770 29783
166. E. Moses, and H.J. Hinz Basic pancreatic trypsin inhibitor has unusual thermodynamic stability parameters J Mol Biol 170 1983 765 776
167. H. Schwarz, H.J. Hinz, A. Mehlich, H. Tschesche, and H.R. Wenzel Stability studies on derivatives of the bovine pancreatic trypsin inhibitor Biochemistry 26 1987 3544 3551
168. M.J. Burgering, L.P. Orbons, A. van der Doelen, J. Mulders, H.J. Theunissen, and P.D. Grootenhuis The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa J Mol Biol 269 1997 395 407
169. W. Bode, and R. Huber Proteinase-protein inhibitor interaction Biomed Biochim Acta 50 1991 437 446
170. W. Bode, and R. Huber Natural protein proteinase inhibitors and their interaction with proteinases Eur J Biochem 204 1992 433 451
171. W.M. Hanson, S.A. Beeser, T.G. Oas, and D.P. Goldenberg Identification of a residue critical for maintaining the functional conformation of BPTI J Mol Biol 333 2003 425 441
172. J.P. Vincent, and M. Lazdunski Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges Biochemistry 11 1972 2967 2977
173. G.J. Broze Jr., L.A. Warren, W.F. Novotny, D.A. Higuchi, J.J. Girard, and J.P. Miletich The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action Blood 71 1988 335 343
174. T.J. Girard, L.A. Warren, W.F. Novotny, K.M. Likert, S.G. Brown, and J.P. Miletich Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor Nature 338 1989 518 520
175. G.J. Broze Jr., G.W. Lange, K.L. Duffin, and L. MacPhail Heterogeneity of plasma tissue factor pathway inhibitor Blood Coagul Fibrinolysis 5 1994 551 559
176. T.M. Hackeng, L.F. Maurissen, E. Castoldi, and J. Rosing Regulation of TFPI function by protein S J Thromb Haemost 7 Suppl. 1 2009 165 168
177. R.J. Baugh, G.J. Broze Jr., and S. Krishnaswamy Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor J Biol Chem 273 1998 4378 4386
178. M. Ndonwi, E.A. Tuley, and G.J. Broze The Kunitz-3 domain of TFPI{alpha} is required for protein S-dependent enhancement of factor Xa inhibition Blood 116 2010 1344 1351
179. 2+ -containing protein S inhibits extrinsic factor X activating complex independently of tissue factor pathway inhibitor (TFPI) J Thromb Haemost 8 2010 1976 1985
180. W.E. Van Nostrand, A.H. Schmaier, J.S. Farrow, D.B. Cines, and D.D. Cunningham Protease nexin-2/amyloid beta-protein precursor in blood is a platelet-specific protein Biochem Biophys Res Commun 175 1991 15 21
181. W.E. Van Nostrand, A.H. Schmaier, J.S. Farrow, and D.D. Cunningham Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein Science 248 1990 745 748
182. W.E. Van Nostrand, S.L. Wagner, J.S. Farrow, and D.D. Cunningham Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor J Biol Chem 265 1990 9591 9594
183. M.S. Wolfe, and S.Y. Guenette APP at a glance J Cell Sci 120 2007 3157 3161
184. F. Xu, J. Davis, J. Miao, M.L. Previti, G. Romanov, and K. Ziegler Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis Proc Natl Acad Sci USA 102 2005 18135 18140
185. F. Xu, M.L. Previti, M.T. Nieman, J. Davis, A.H. Schmaier, and W.E. Van Nostrand AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis J Neurosci 29 2009 5666 5670
186. D. Navaneetham, L. Jin, P. Pandey, J.E. Strickler, R.E. Babine, and S.S. Abdel-Meguid Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2 J Biol Chem 280 2005 36165 36175
187. A.H. Schmaier, L.D. Dahl, A.J. Rozemuller, R.A. Roos, S.L. Wagner, and R. Chung Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa J Clin Invest 92 1993 2540 2545
188. F. Mahdi, W.E. Van Nostrand, and A.H. Schmaier Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex J Biol Chem 270 1995 23468 23474
189. M.G. Grutter, J.P. Priestle, J. Rahuel, H. Grossenbacher, W. Bode, and J. Hofsteenge Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition EMBO J 9 1990 2361 2365
190. T.J. Rydel, K.G. Ravichandran, A. Tulinsky, W. Bode, R. Huber, and C. Roitsch The structure of a complex of recombinant hirudin and human alpha-thrombin Science 249 1990 277 280
191. H. Isawa, M. Yuda, K. Yoneda, and Y. Chinzei The insect salivary protein, prolixin-S, inhibits factor IXa generation and Xase complex formation in the blood coagulation pathway J Biol Chem 275 2000 6636 6641
192. N.P. Gudderra, J.M. Ribeiro, and J.F. Andersen Structural determinants of factor IX(a) binding in nitrophorin 2, a lipocalin inhibitor of the intrinsic coagulation pathway J Biol Chem 280 2005 25022 25028
193. J.F. Andersen, and W.R. Montfort The crystal structure of nitrophorin 2. A trifunctional antihemostatic protein from the saliva of Rhodnius prolixus J Biol Chem 275 2000 30496 30503
194. H. Mizuno, Z. Fujimoto, M. Koizumi, H. Kano, H. Atoda, and T. Morita Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 : implication of central loop swapping based on deletion in the linker region J Mol Biol 289 1999 103 112
195. H. Mizuno, Z. Fujimoto, M. Koizumi, H. Kano, H. Atoda, and T. Morita Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains Nat Struct Biol 4 1997 438 441
196. H. Mizuno, Z. Fujimoto, H. Atoda, and T. Morita Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X Proc Natl Acad Sci USA 98 2001 7230 7234
197. I.M. Francischetti, J.G. Valenzuela, J.F. Andersen, T.N. Mather, and J.M. Ribeiro Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex Blood 99 2002 3602 3612
198. R.Q. Monteiro, A.R. Rezaie, J.S. Bae, E. Calvo, J.F. Andersen, and I.M. Francischetti Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite Protein Sci 17 2008 146 153
199. L. Waxman, D.E. Smith, K.E. Arcuri, and G.P. Vlasuk Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa Science 248 1990 593 596
200. A. van de Locht, M.T. Stubbs, W. Bode, T. Friedrich, C. Bollschweiler, and W. Hoffken The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J 15 1996 6011 6017
201. A. Wei, R.S. Alexander, J. Duke, H. Ross, S.A. Rosenfeld, and C.H. Chang Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa J Mol Biol 283 1998 147 154
202. S. Krishnaswamy, G.P. Vlasuk, and P.W. Bergum Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide Biochemistry 33 1994 7897 7907
203. P. Stassens, P.W. Bergum, Y. Gansemans, L. Jespers, Y. Laroche, and S. Huang Anticoagulant repertoire of the hookworm Ancylostoma caninum Proc Natl Acad Sci USA 93 1996 2149 2154
204. J.L. Rios-Steiner, M.T. Murakami, A. Tulinsky, and R.K. Arni Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum J Mol Biol 371 2007 774 786
205. S. Ehrenforth, W. Kreuz, I. Scharrer, R. Linde, M. Funk, and T. Gungor Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs Lancet 339 1992 594 598
206. F.B. Hollinger, G. Dolana, W. Thomas, and F. Gyorkey Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate J Infect Dis 150 1984 250 262
207. J.S. Cervia, S.O. Sowemimo-Coker, G.A. Ortolano, K. Wilkins, J. Schaffer, and S.T. Wortham An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease Transfus Med Rev 20 2006 190 206
208. F. Houston, S. McCutcheon, W. Goldmann, A. Chong, J. Foster, and S. Siso Prion diseases are efficiently transmitted by blood transfusion in sheep Blood 112 2008 4739 4745
209. P. Galeffi, and G.G. Brownlee The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4 Nucleic Acids Res 15 1987 9505 9513
210. J.W. Suttie Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid CRC Crit Rev Biochem 8 1980 191 223
211. L.C. Wasley, A. Rehemtulla, J.A. Bristol, and R.J. Kaufman PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway J Biol Chem 268 1993 8458 8465
212. G.C. White 2nd, E.M. Pickens, D.K. Liles, and H.R. Roberts Mammalian recombinant coagulation proteins: structure and function Transfus Sci 19 1998 177 189
213. M.D. Blostein, A.C. Rigby, B.C. Furie, B. Furie, and G.E. Gilbert Amphipathic helices support function of blood coagulation factor IXa Biochemistry 39 2000 12000 12006
214. J.G. Ganopolsky, S. Charbonneau, H.T. Peng, P.N. Shek, and M.D. Blostein Characterization of an ideal amphipathic peptide as a procoagulant agent Biochem J 412 2008 545 551
215. J.A. Lopez, and J. Chen Pathophysiology of venous thrombosis Thromb Res 123 Suppl. 4 2009 S30 34
216. A. Girolami, R. Scandellari, E. Zanon, R. Sartori, and B. Girolami Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases J Thromb Thrombolysis 21 2006 279 284
217. T. Chen, and S. Lam Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolism Cardiol Rev 17 2009 192 197
218. A. Batorova Advances in antithrombotic treatmentAntithrombotics with anti-Xa effect Vnitr Lk 55 2009 295 301
219. A.G. Turpie, K.A. Bauer, B.L. Davidson, W.D. Fisher, M. Gent, and M.H. Huo A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) Thromb Haemost 101 2009 68 76
220. G. Agnelli, B.I. Eriksson, A.T. Cohen, D. Bergqvist, O.E. Dahl, and M.R. Lassen Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran Thromb Res 123 2009 488 497